Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Financial Stocks Dominate Pzena Investment Management’s Equity Portfolio at the End of June

Page 1 of 2

Pzena Investment Management is a New York-based value-focused hedge fund established by Richard S. Pzena in 1995, which has recently filed its 13F filing. The filing disclosed that, at the end of June, Pzena’s equity portfolio was worth over $17.72 billion and was heavily dominated by stocks from the financial sector, which accounted for 37% of the total value. Moreover, as of June 30, Hewlett-Packard Company (NYSE:HPQ), Citigroup Inc (NYSE:C), and American International Group Inc (NYSE:AIG) represent Pzena Investment Management’s top three holdings.

Richard Pzena - Pzena Investment Management

Mr. Pzena holds a BS summa cum laude and an MBA from the Wharton School of the University of Pennsylvania and prior to starting Pzena Investment Management served as the Director of U.S. Equity Investments and Chief Research Officer for Sanford C. Bernstein & Company. As of June 30, 2015 the fund had $28 billion in assets under management (AUM) and employed 89 people across its offices at New York, London and Melbourne.

We track activity of funds like Pzena Investment Management as a part of our small-cap strategy. In 2014, equity hedge funds returned just 1.4%. In 2013 and 2012, these figures amounted to 11.3% and 4.8%, respectively, which is significantly below the average market returns for the same periods. This doesn’t mean that hedge funds are not capable of identifying profitable opportunities. For example, our small-cap hedge fund strategy, which identifies the best small-cap stock picks of the best hedge fund managers returned 28.2% in 2014, 53.2% in 2013, and 33.3% in 2012, outperforming the market each year. What’s the reason for this discrepancy you may ask? The reason is simple: size. Hedge funds have gotten so large, they have to allocate the majority of their money into large-cap liquid stocks that are more efficiently priced. In this way, it turns out that it is actually hedge funds’ small-cap ideas that are their best performing ones and we have consistently identified the best picks of the best managers, returning 123% since August 2012, compared to around 58% for the S&P 500 ETF (SPY) (see more details).

Richard S. Pzena
Richard S. Pzena
Pzena Investment Management

Pzena Investment Management increased its stake in Hewlett-Packard Company (NYSE:HPQ) by 301,655 shares during the second quarter to almost 18 million shares valued at $540 million. Amid weak PC sales, the stock of Hewlett-Packard Company (NYSE:HPQ) lost 24% since the beginning of the year. Hewlett-Packard Company (NYSE:HPQ) currently plans a split of its enterprise and consumer-focused businesses by the end of the year, following which both segments will become independent companies. Most experts are viewing this separation as a possibility to unlock significant value for shareholders. Hewlett-Packard Company (NYSE:HPQ) is also slowly ramping up its cloud and mobility business as was evident from the company’s acquisition of Aruba Networks earlier in May and its purchase of Stackato, a PaaS (platform-as-a-service product) from ActiveState last month. Pzena Investment Management was the largest shareholder of Hewlett-Packard Company (NYSE:HPQ) at the end of first quarter among the hedge funds we cover, followed by Cliff Asness‘ AQR Capital Management which increased its stake to over 10.5 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!